These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 36435784)

  • 21. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
    Jellinger KA
    Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of VAPB and vesicular profiles in α-synuclein aggregates in multiple system atrophy.
    Mori F; Miki Y; Tanji K; Kon T; Tomiyama M; Kakita A; Wakabayashi K
    Brain Pathol; 2021 Nov; 31(6):e13001. PubMed ID: 34196429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
    Stemberger S; Poewe W; Wenning GK; Stefanova N
    Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial impairment and oxidative stress compromise autophagosomal degradation of α-synuclein in oligodendroglial cells.
    Pukaß K; Goldbaum O; Richter-Landsberg C
    J Neurochem; 2015 Oct; 135(1):194-205. PubMed ID: 26212128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.
    Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH
    Neurobiol Dis; 2014 Mar; 63():171-83. PubMed ID: 24361600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.
    May VE; Ettle B; Poehler AM; Nuber S; Ubhi K; Rockenstein E; Winner B; Wegner M; Masliah E; Winkler J
    Neurobiol Aging; 2014 Oct; 35(10):2357-68. PubMed ID: 24698767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.
    Jellinger KA
    J Alzheimers Dis; 2018; 62(3):1141-1179. PubMed ID: 28984582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.
    Nakayama K; Suzuki Y; Yazawa I
    Am J Pathol; 2009 Apr; 174(4):1471-80. PubMed ID: 19286568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.
    Kahle PJ; Neumann M; Ozmen L; Muller V; Jacobsen H; Spooren W; Fuss B; Mallon B; Macklin WB; Fujiwara H; Hasegawa M; Iwatsubo T; Kretzschmar HA; Haass C
    EMBO Rep; 2002 Jun; 3(6):583-8. PubMed ID: 12034752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy.
    Abdul-Rahman T; Herrera-Calderón RE; Ahluwalia A; Wireko AA; Ferreira T; Tan JK; Wolfson M; Ghosh S; Horbas V; Garg V; Perveen A; Papadakis M; Ashraf GM; Alexiou A
    CNS Neurosci Ther; 2024 Apr; 30(4):e14678. PubMed ID: 38572788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates.
    Valdinocci D; Grant GD; Dickson TC; Pountney DL
    Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MOBP and HIP1 in multiple system atrophy: New α-synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis.
    Bettencourt C; Miki Y; Piras IS; de Silva R; Foti SC; Talboom JS; Revesz T; Lashley T; Balazs R; Viré E; Warner TT; Huentelman MJ; Holton JL
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):640-652. PubMed ID: 33368549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.
    Peng C; Gathagan RJ; Covell DJ; Medellin C; Stieber A; Robinson JL; Zhang B; Pitkin RM; Olufemi MF; Luk KC; Trojanowski JQ; Lee VM
    Nature; 2018 May; 557(7706):558-563. PubMed ID: 29743672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-synuclein mRNA expression in oligodendrocytes in MSA.
    Asi YT; Simpson JE; Heath PR; Wharton SB; Lees AJ; Revesz T; Houlden H; Holton JL
    Glia; 2014 Jun; 62(6):964-70. PubMed ID: 24590631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
    Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
    Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
    Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
    Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.